The University Biosafety Committee provides review and approval of all recombinant DNA research,
including Human Gene Transfer clinical trials, and review and approval of all Select Agents Research.
Protocols are reviewed and overseen for compliance with the National Institute of Health (NIH) Guidelines
and Federal Select Agents Regulations.
IBC Compliance Note: NIH Guidelines
The IBC meets monthly to review to and approve Biosafety Applications.
Responsibilities of the IBC
- Review and approval of research involving recombinant DNA materials, including transgenic animals, plants and Human Subjects Gene Transfer clinical trials for regulatory compliance, safety, and containment of biological materials.
- Review and approval of Biosafety Authorization Forms for work with infectious biological materials for regulatory compliance, safety, and containment of biological materials.
- Review and approval of Biosafety Authorization Forms for all work with Select Agents Toxins for regulatory compliance, safety, and containment of SA materials.
- Incident Reporting and Investigations for incidents involving infectious or recombinant DNA materials.
Biosafety Authorization Forms
Any IBC applications submitted after 12:00pm on 01February2018 must be entered in the eSirius system- word files will not be accepted for any applications after that time. Please contact email@example.com with questions regarding the new application management system.
You can download any form as a Word Document, fill it out and send it directly to the IBC at
If you have questions about what types of forms are required please contact